Literature DB >> 24228270

1H NMR-based metabonomic analysis of serum and urine in a nonhuman primate model of diabetic nephropathy.

Jingping Liu, Dan Wang, Younan Chen, Hongjie Sun, Sirong He, Chengshi Wang, Guang Yang, Meimei Shi, Jie Zhang, Yan Ren, Li Wang, Yanrong Lu, Jingqiu Cheng.   

Abstract

Diabetic nephropathy (DN) is a serious metabolic disease, and comprehensive understanding of its complex mechanism will help in preventing the onset and progression of DN. To reveal the systemic metabolic changes associated with renal injury, we performed 1H NMR-based metabonomic and multivariate analyses to analyze serum and urine obtained from a nonhuman primate model of DN. Our results indicated that DN monkeys exhibited a distinct metabolic profile, including higher levels of VLDL/LDL, lipids, unsaturated lipids, uric acid, allantoin, fumarate and hippurate, as well as lower levels of HDL, alanine, glutamate, pyruvate, formate, tyrosine, histidine and NAD+. The disturbed metabolic pathways were further identified, including NAD+ metabolism, purine metabolism, oxidative stress, lipid metabolism, and renal tubular reabsorption. This study highlights that NMR-based metabonomics provides insight into the underlying pathways in the pathogenesis and progression of DN at the metabolic level.

Entities:  

Mesh:

Year:  2013        PMID: 24228270     DOI: 10.1039/c3mb70212j

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  15 in total

1.  Candidate metabolite markers of peripheral neuropathy in Chinese patients with type 2 diabetes.

Authors:  Ming-Mei Shao; Hong-Jiao Xiang; Hao Lu; Pei-Hao Yin; Guo-Wen Li; Yun-Man Wang; Lin Chen; Qing-Guang Chen; Cheng Zhao; Qun Lu; Tao Wu; Guang Ji
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

2.  A longitudinal analysis of the effects of age on the blood plasma metabolome in the common marmoset, Callithrix jacchus.

Authors:  Jessica M Hoffman; ViLinh Tran; Lynn M Wachtman; Cara L Green; Dean P Jones; Daniel E L Promislow
Journal:  Exp Gerontol       Date:  2016-01-21       Impact factor: 4.032

Review 3.  Mitochondrial dysfunction in diabetic kidney disease.

Authors:  Josephine M Forbes; David R Thorburn
Journal:  Nat Rev Nephrol       Date:  2018-02-19       Impact factor: 28.314

4.  Functionalized self-assembling peptide improves INS-1 β-cell function and proliferation via the integrin/FAK/ERK/cyclin pathway.

Authors:  Jingping Liu; Shuyun Liu; Younan Chen; Xiaojun Zhao; Yanrong Lu; Jingqiu Cheng
Journal:  Int J Nanomedicine       Date:  2015-05-13

5.  Metabonomic analysis of potential biomarkers and drug targets involved in diabetic nephropathy mice.

Authors:  Tingting Wei; Liangcai Zhao; Jianmin Jia; Huanhuan Xia; Yao Du; Qiuting Lin; Xiaodong Lin; Xinjian Ye; Zhihan Yan; Hongchang Gao
Journal:  Sci Rep       Date:  2015-07-07       Impact factor: 4.379

6.  C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathway.

Authors:  Ling Li; Qinghua Yin; Xi Tang; Lin Bai; Jie Zhang; Shenju Gou; Hongping Zhu; Jingqiu Cheng; Ping Fu; Fang Liu
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

7.  Phloretin attenuates hyperuricemia-induced endothelial dysfunction through co-inhibiting inflammation and GLUT9-mediated uric acid uptake.

Authors:  Shuyun Liu; Yujia Yuan; Yijie Zhou; Meng Zhao; Younan Chen; Jingqiu Cheng; Yanrong Lu; Jingping Liu
Journal:  J Cell Mol Med       Date:  2017-04-12       Impact factor: 5.310

Review 8.  Metabolomics window into diabetic complications.

Authors:  Tao Wu; Shuxuan Qiao; Chenze Shi; Shuya Wang; Guang Ji
Journal:  J Diabetes Investig       Date:  2017-09-13       Impact factor: 4.232

9.  1H NMR-based metabolomic study of metabolic profiling for pollinosis.

Authors:  Yan-Jun Zhou; Li-Sha Li; Jin-Lu Sun; Kai Guan; Ji-Fu Wei
Journal:  World Allergy Organ J       Date:  2019-01-26       Impact factor: 4.084

10.  Metabolomics window into the role of acute kidney injury after coronary artery bypass grafting in diabetic nephropathy progression.

Authors:  Jiayi Wang; Wenzhe Yan; Xiang Zhou; Yu Liu; Chengyuan Tang; Youming Peng; Hong Liu; Lin Sun; Li Xiao; Liyu He
Journal:  PeerJ       Date:  2020-05-14       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.